York Space Systems Inc. 8-K
Research Summary
AI-generated summary
York Space Systems Announces Merger to Acquire All.Space for $355M
What Happened
York Space Systems Inc. announced on April 29, 2026 (Form 8-K) that it entered into an Agreement and Plan of Merger to acquire All.Space Holdings, Inc. through a series of contributions and mergers that will make All.Space an indirect wholly owned subsidiary. The aggregate purchase price at closing is $355 million, subject to customary closing adjustments. The company expects to fund the deal with approximately $155 million in cash and to issue up to 5.9 million York Space Systems common shares.
Key Details
- Deal date: April 29, 2026 (Merger Agreement signed).
- Purchase Price: $355 million aggregate, subject to adjustments for cash, indebtedness, transaction expenses and net working capital.
- Consideration: Expected ~ $155 million cash + up to 5.9 million YSS shares issued at Closing (final mix determined per agreement).
- Escrows/reserves at Closing: $5.0M adjustment escrow, $1.5M reorganization indemnity escrow, BGP 750,000 (converted to USD at Closing) special indemnity escrow, and $1.0M expense reserve fund.
- Other items: Company obtaining representations & warranty insurance; Securityholders face transfer restrictions (50% of shares locked for 6 months, remaining 50% for 9 months).
- Closing conditions: Subject to customary conditions and required regulatory approvals/clearances (including antitrust, foreign investment and telecommunications). Outside Date: 120 days with up to 90 days of extensions for pending regulatory approvals.
Why It Matters
This is a material acquisition for York Space Systems that will add All.Space to its consolidated business and is financed with a mix of cash and stock, which can affect YSS liquidity and share count. The deal requires regulatory approvals and has customary escrow and indemnity protections; successful closing or any delays could affect YSS’s near-term financial position and share dilution. Investors should watch for regulatory clearance updates, final allocation of cash vs. stock consideration, and any financing or restructuring impacts disclosed in future filings.